Frank Lichtenberg

Courtney C. Brown Professor of Business

Finance and Economics

Courtney C. Brown Professor of Business

Healthcare and Pharmaceutical Management Program

BA, University of Chicago, 1973; MA, University of Pennsylvania, 1976; PhD, 1982

Joined CBS in 1983

Download Curriculum Vitae (PDF)

Frank Lichtenberg

Office
504 Uris

Phone
212-854-4408

E-mail
frl1@columbia.edu

Fax
212-854-7647

Teaching and research interest

Professor Lichtenberg teaches the elective course Economics of Health Care & Pharmaceuticals in the MBA and EMBA programs. His research examines how the introduction of new technology arising from research and development affects the productivity of companies, industries and nations. He has studied the impact of biomedical innovation on longevity and quality of life, the consequences of takeovers and LBOs for efficiency and employment, and the effect of computers on productivity in business and government organizations. A research associate of the National Bureau of Economic Research, Lichtenberg has received numerous research fellowships and grants, served as a consultant to a variety of private and public organizations and testified before Congress.

Honors and awards

Chapters

Pharmaceutical Knowledge-Capital Accumulation and Longevity In Measuring Capital in the New Economy (2005)
Author(s): Frank Lichtenberg

More Information Download (PDF)

Journal articles

The contribution of pharmaceutical innovation to longevity growth in Germany and France, 2001–2007 In PharmacoEconomics (2012)
Author(s): Frank Lichtenberg

More Information Download (PDF)

Has Pharmaceutical Innovation Reduced Social Security Disability Growth? In International Journal of the Economics of Business (2011)
Author(s): Frank Lichtenberg

More Information Download (PDF)

Despite steep costs, payments for new cancer drugs make economic sense In Nature Medicine (2011)
Author(s): Frank Lichtenberg

More Information Download (PDF)

The quality of medical care, behavioral risk factors, and longevity growth In International Journal of Health Care Finance and Economics (2011)
Author(s): Frank Lichtenberg

More Information

What Are the Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation? In Health Affairs (2011)
Author(s): Frank Lichtenberg, Bhaven Sampat

More Information

Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia In Forum for Health Economics & Policy (2010)
Author(s): Frank Lichtenberg

More Information Download (PDF)

Pharmaceutical innovation and mortality in the United States, 1960–2000. A commentary on Schnittker and Karandinos In Social Science and Medicine (2010)
Author(s): Frank Lichtenberg

More Information

Pharmaceutical Price Discrimination and Social Welfare In Capitalism and Society (2010)
Author(s): Frank Lichtenberg

More Information Download (PDF)

The effect of drug vintage on survival: Micro evidence from Puerto Rico's Medicaid program In Advances in health economics and health services research (2010)
Author(s): Frank Lichtenberg

More Information Download (PDF)

Availability of New Drugs and Americans' Ability to Work In Journal of Occupational and Environmental Medicine (2005)
Author(s): Frank Lichtenberg

More Information Download (PDF)

The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001 In International Journal of Health Care Finance and Economics (2005)
Author(s): Frank Lichtenberg

More Information Download (PDF)

The Effects of Medicare on Health Care Utilization and Outcomes In Frontiers in Health Policy Research (2002)
Author(s): Frank Lichtenberg

More Information Download (PDF)

Do (More and Better) Drugs Keep People Out of Hospitals? In American Economic Review (1996)
Author(s): Frank Lichtenberg

More Information Download (PDF)

The Private R and D Investment Response to Federal Design and Technical Competitions In American Economic Review (1988)
Author(s): Frank Lichtenberg

More Information Download (PDF)

The Comparative Advantage of Educated Workers in Implementing New Technology In Review of Economics and Statistics (1987)
Author(s): Ann Bartel, Frank Lichtenberg

More Information Download (PDF)

Books

Corporate Takeovers and Productivity (1992)
Author(s): Frank Lichtenberg

More Information

Working Papers

The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data Working Paper No. 19593 (2013)
Author(s): Frank Lichtenberg

More Information Download (PDF)

The Impact of New (Orphan) Drug Approvals on Premature Mortality from Rare Diseases in the U.S. and France, 1999–2007 Working Paper (2011)
Author(s): Frank Lichtenberg

More Information Download (PDF)

Has medical innovation reduced cancer mortality? Working Paper No. 15880 (2010)
Author(s): Frank Lichtenberg

More Information Download (PDF)

Is Home Health Care a Substitute for Hospital Care? Working paper (2010)
Author(s): Frank Lichtenberg

More Information Download (PDF)

The impact of medical knowledge accumulation and diffusion on health: Evidence from Medline and other N.I.H. data Working paper (2010)
Author(s): Frank Lichtenberg

More Information Download (PDF)

The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth NBER Working Papers, Working Paper 15068 (2009)
Author(s): Frank Lichtenberg

More Information Download (PDF)

Benefits and Costs of Newer Drugs: An Update Working paper (2005)
Author(s): Frank Lichtenberg

More Information

Pharmaceutical-Embodied Technical Progress, Longevity, and Quality of Life: Drugs as 'Equipment for Your Health' Working paper (2005)
Author(s): Frank Lichtenberg, Suchin Virabhak

More Information

Sources of U.S. Longevity Increase, 1960-1997 Working paper (2005)
Author(s): Frank Lichtenberg

More Information

The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry Working paper (2005)
Author(s): Frank Lichtenberg

More Information

The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output Working paper (2005)
Author(s): Frank Lichtenberg

More Information

The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs? Working paper (2005)
Author(s): Adriana Lleras-Muney, Frank Lichtenberg

More Information

The Expanding Pharmaceutical Arsenal in the War on Cancer NBR Working Paper 10328 (2005)
Author(s): Frank Lichtenberg

More Information Download (PDF)

The Impact of New Drug Launches on Longevity: From 52 Countries, 1982-2001 Working paper (2005)
Author(s): Frank Lichtenberg

More Information Download (PDF)

The Effect of New Drugs on Mortality from Rare Diseases and HIV NBER Working Paper 8677 (2002)
Author(s): Frank Lichtenberg

More Information

The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey NBER Working Paper 8147 (2001)
Author(s): Frank Lichtenberg

More Information

Pharmaceutical Innovation, Mortality Reduction, and Economic Growth NBER Working Paper W6569 (1998)
Author(s): Frank Lichtenberg

More Information

The Allocation of Publicly-Funded Biomedical Research NBER Working Paper 6601 (1998)
Author(s): Frank Lichtenberg

More Information

The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality NBER Working Paper No. W5418 (1996)
Author(s): Frank Lichtenberg

More Information